Arcioni F.; Roncadori A.; Di Battista V.; Tura S.; Covezzoli A.; Cundari S.; Mecucci C.; Abbadessa A.; Alterini R.; Santini V.; Cantonetti M.; Buccisano F.; Bacigalupo A.; Sessarego M.; Tonso A.; Ferrero D.; D'Ardia S.; Tarella C.; Cascavilla N.; Bassan R.; Sancetta R.; Cortelezzi A.; Reda G.; Maria D'Arco A.; De Fabritiis P.; Di Renzo N.; Falini B.; Alimena G.; Avanzini P.; Ilariucci F.; Iuliano F.; La Nasa G.; Caocci G.; Defina M.; Latte G.; Palmas A.; Levis A.; Leone G.; Teresa Voso M.; Leoni P.; Poloni A.; Fozza C.; Crugnola M.; Montanaro M.; Spedini P.; Lanza F.; Pizzuti M.; Pane F.; Paolini R.; Borin L.; Rambaldi A.; Rossi G.; Maria Pelizzari A.; Russo D.; D'Emilio A.; Ruggeri M.; Semenzato G.; Specchia G.; Tagariello G.; Sartori R.; Testore F.; Ciravegna G.; Marasca R.; Cimarosto L.; Fontanive O.; Visani G., Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2018, 101, pp. 78 - 85 [Scientific article]
Mohty, Mohamad; Terpos, Evangelos; Mateos, Maria-Victoria; Cavo, Michele; Lejniece, Sandra; Beksac, Meral; Bekadja, Mohamed Amine; Legiec, Wojciech; Dimopoulos, Meletios; Stankovic, Svetlana; Durán, Maria Soledad; De Stefano, Valerio; Corso, Alessandro; Kochkareva, Yulia; Laane, Edward; Berthou, Christian; Salwender, Hans; Masliak, Zvenyslava; Pečeliūnas, Valdas; Willenbacher, Wolfgang; Silva, João; Louw, Vernon; Nemet, Damir; Borbényi, Zita; Abadi, Uri; Pedersen, Robert Schou; Černelč, Peter; Potamianou, Anna; Couturier, Catherine; Feys, Caroline; Thoret-Bauchet, Florence; Boccadoro, Mario; Lanza, Francesco;, Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2018, 18, pp. 401 - 419 [Scientific article]Open Access
Olivieri J.; Attolico I.; Nuccorini R.; Pascale S. P.; Chiarucci M.; Poiani M.; Corradini P.; Farina L.; Gaidano G.; Nassi L.; Sica S.; Piccirillo N.; Pioltelli P. E.; Martino M.; Moscato T.; Pini M.; Zallio F.; Ciceri F.; Marktel S.; Mengarelli A.; Musto P.; Capria S.; Merli F.; Codeluppi K.; Mele G.; Lanza F.; Specchia G.; Pastore D.; Milone G.; Saraceni F.; Di Nardo E.; Perseghin P.; Olivieri A., Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score, «BONE MARROW TRANSPLANTATION», 2018, 53, pp. 461 - 473 [Scientific article]
Mohty M.; Duarte R. F.; Kuball J.; Bader P.; Basak G. W.; Bonini C.; Carreras E.; Chabannon C.; Dufour C.; Gennery A.; Lankester A.; Lanza F.; Ljungman P.; Montoto S.; Nagler A.; Snowden J. A.; Styczynski J.; Sureda A.; Kroger N., Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation, «BONE MARROW TRANSPLANTATION», 2018, 53, pp. 1548 - 1552 [Scientific article]
Necchi A.; Lo Vullo S.; Secondino S.; Rosti G.; Badoglio M.; Giannatempo P.; Raggi D.; Lanza F.; Chabannon C.; Bonini C.; Mariani L.; Pedrazzoli P., Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: A 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT), «BONE MARROW TRANSPLANTATION», 2018, 53, pp. 722 - 728 [Scientific article]
Saraceni F.; Beohou E.; Labopin M.; Arcese W.; Bonifazi F.; Stepensky P.; Aljurf M.; Bruno B.; Pioltelli P.; Passweg J.; Socie G.; Santarone S.; Yakoub-Agha I.; Lanza F.; Savani B. N.; Mohty M.; Nagler A., Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia, «AMERICAN JOURNAL OF HEMATOLOGY», 2018, 93, pp. 1211 - 1219 [Scientific article]
Lanza F.; Saraceni F.; Pezzi A.; Martino M.; Bosi A.; Cascavilla N.; Musto P.; Zuffa E.; Tani M.; Cellini C.; Laszlo D.; Bonifazi F., A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach, «AMERICAN JOURNAL OF HEMATOLOGY», 2017, 92, pp. E557 - E559 [Scientific article]
Necchi A.; Lo Vullo S.; Rosti G.; Badoglio M.; Giannatempo P.; Raggi D.; Secondino S.; Mariani L.; Lanza F.; Pedrazzoli P., Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database, «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 1218 - 1220 [Scientific article]
Gratwohl A.; Sureda A.; Cornelissen J.; Apperley J.; Dreger P.; Duarte R.; Greinix H. T.; Mc Grath E.; Kroeger N.; Lanza F.; Nagler A.; Snowden J. A.; Niederwieser D.; Brand R., Alloreactivity: the Janus-face of hematopoietic stem cell transplantation, «LEUKEMIA», 2017, 31, pp. 1752 - 1759 [Scientific article]Open Access
De Giorgi U.; Nicolas-Virelizier E.; Badoglio M.; Bader P.; Richard S.; Maertens J.; Lanza F.; Bregni M., High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation, «INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER», 2017, 27, pp. 248 - 251 [Scientific article]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Kuball J.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Nagler A.; Sureda A.; Mohty M., Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT), «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 191 - 196 [Scientific article]
Necchi A.; Lo Vullo S.; Bregni M.; Rosti G.; Mariani L.; Raggi D.; Giannatempo P.; Secondino S.; Schumacher K.; Massard C.; Kanfer E.; Oechsle K.; Laszlo D.; Michieli M.; Ifrah N.; Mercier M.; Crysandt M.; Wuchter P.; Nagler A.; Wahlin A.; Martino M.; Badoglio M.; Pedrazzoli P.; Lanza F., Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012, «CLINICAL GENITOURINARY CANCER», 2017, 15, pp. 163 - 167 [Scientific article]
De Giorgi U.; Richard S.; Badoglio M.; Kanfer E.; Bourrhis J. H.; Nicolas-Virelizier E.; Vettenranta K.; Lioure B.; Martin S.; Dreger P.; Schuler M. K.; Thomson K.; Scarpi E.; Rosti G.; Selle F.; Mangili G.; Lanza F.; Bregni M., Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: A retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT), «ANNALS OF ONCOLOGY», 2017, 28, pp. 1910 - 1916 [Scientific article]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Duarte R. F.; Dufour C.; Gennery A.; Kroger N.; Kuball J.; Lanza F.; Montoto S.; Nagler A.; Snowden J. A.; Styczynski J.; Mohty M., Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report, «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 811 - 817 [Scientific article]
Trojani, Alessandra; Pungolino, Ester; Rossi, Giuseppe; D'Adda, Mariella; Lodola, Milena; Camillo, Barbara Di; Perego, Alessandra; Turrini, Mauro; Orlandi, Ester; Borin, Lorenza; Iurlo, Alessandra; Malato, Simona; Spina, Francesco; Latargia, Maria Luisa; Lanza, Francesco; Artale, Salvatore; Anghilieri, Michela; Carraro, Maria Cristina; Canal, Gabriella De; Morra, Enrica; Cairoli, Roberto, Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment, «DISEASE MARKERS. SECTION A, CANCER BIOMARKERS», 2017, 21, pp. 41 - 53 [Scientific article]
